clinical trial · NCT03237481
Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)
Postoperative PainHTX-011Bupivacaine HClSaline placeboLuer-lock applicatorVial access device
brief summary
This is a Phase 3, randomized, double-blind, saline placebo- and active-controlled, multicenter study to evaluate the analgesic efficacy and safety of HTX 011 administered via local administration into the surgical site in subjects undergoing unilateral open inguinal herniorrhaphy.
started
Jul 31, 2017
primary completion
Dec 22, 2017
completion
Jan 16, 2018
last updated
Mar 2, 2026
official title
A Phase 3, Randomized, Double Blind, Saline Placebo and Active Controlled, Multicenter Study of HTX 011 Via Local Administration for Postoperative Analgesia and Decreased Opioid Use Following Unilateral Open Inguinal Herniorrhaphy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol